US 10512649
Methods and compositions for treatment of zika virus infection
granted A61KA61K31/519A61K45/06
Quick answer
US patent 10512649 (Methods and compositions for treatment of zika virus infection) held by BioCryst Pharmaceuticals, Inc. expires Mon Dec 19 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- BioCryst Pharmaceuticals, Inc.
- Grant date
- Tue Dec 24 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 19 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 22
- CPC classes
- A61K, A61K31/519, A61K45/06, A61K9/0019, A61K9/0053